{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:47:04Z","timestamp":1791658024859,"version":"4.3.4"},"reference-count":32,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The self controlled case series (SCCS) is one of the most promising methods for drug safety signal detection using real world data (RWD), and incorporating active comparators could potentially improve its performance by addressing time\u2010varying confounding by indication. The \u2018Syst\u00e8me National des Donn\u00e9es de Sant\u00e9\u2019 (SNDS) is a large nationwide administrative claims database, which has not been used extensively for drug safety signal detection. While comparable in size to other RWD sources, it is unclear to what extent the performance of SCCS correlates with that in other sources.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aims to evaluate the performance of the SCCS with and without active comparators for signal detection in the French administrative healthcare database SNDS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We applied the SCCS to macrolide and fluoroquinolone antibiotics, using amoxicillin as the active comparator. Amoxicillin was chosen as an active comparator with similar indications. In total, 7 drugs and 30 outcomes from all organ classes were selected. We developed a reference set of 104 positive controls and 58 negative controls, using a taxonomy framework to ensure the selected drug outcome pairs are theoretically well suited to the SCCS design. The observation period lasted 2\u2009years, with a 30\u2010day risk window after each dispensing. Diagnostic performance was measured using sensitivity and specificity with respect to the product labels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The sensitivity and specificity of the SCCS without active comparator were 0.89 and 0.43, respectively, when limited to pairs with satisfactory power. Specificity increased up to 0.91 with active comparators; however, sensitivity decreased to 0.52.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The SNDS is a useful data source for signal detection, particularly for outcomes captured in hospitals. Using a carefully designed reference set of drug\u2010outcome pairs well suited to the study design, the SCCS achieved satisfactory performance for signal detection in this database. In this study, the use of active comparators improved overall performance at the expense of greatly reduced sensitivity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/pds.70224","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T11:31:43Z","timestamp":1763119903000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Performance of the Self\u2010Controlled Case Series With Active Comparators for Drug Safety Signal Detection Using the French Administrative Healthcare Database (\n                    <scp>SNDS<\/scp>\n                    )"],"prefix":"10.1002","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4207-7447","authenticated-orcid":false,"given":"Astrid","family":"Coste","sequence":"first","affiliation":[{"name":"Department of Non\u2010Communicable Diseases Epidemiology LSHTM  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8618-7333","authenticated-orcid":false,"given":"Angel Y. S.","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Non\u2010Communicable Diseases Epidemiology LSHTM  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Haguinet","sequence":"additional","affiliation":[{"name":"GSK  Wavre Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3151-3653","authenticated-orcid":false,"given":"Andrew","family":"Bate","sequence":"additional","affiliation":[{"name":"Department of Non\u2010Communicable Diseases Epidemiology LSHTM  London UK"},{"name":"GSK  Wavre Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian J.","family":"Douglas","sequence":"additional","affiliation":[{"name":"Department of Non\u2010Communicable Diseases Epidemiology LSHTM  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"e_1_2_9_2_1","unstructured":"Assurance Maladie \u201cPr\u00e9sentation du syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) \u201d2024."},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2024.05.003"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5038"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5161"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4065"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2017.1325463"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5548"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e31825f63bf"},{"key":"e_1_2_9_10_1","unstructured":"S. N.Murphy V.Castro J.Colecchi A.Dubey V.Gainer andC.Herrick \u201cPartners HealthCare OMOP Study Report \u201d2011."},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-013-0108-9"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5620"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-013-0109-8"},{"key":"e_1_2_9_14_1","first-page":"13","article-title":"Vaccine Safety Surveillance Using Routinely Collected Healthcare Data\u2014An Empirical Evaluation of Epidemiological Designs","volume":"13","author":"Schuemie M. J.","year":"2022","journal-title":"Frontiers in Pharmacology"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1162\/99608f92.147cc28e"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwab110"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.70036"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwae216"},{"issue":"2","key":"e_1_2_9_19_1","first-page":"215","article-title":"French Administrative Health Care Database (SNDS): The Value of Its Enrichment","volume":"74","author":"Scailteux L.\u2010M.","year":"2018","journal-title":"Pharmacoepidemiology"},{"key":"e_1_2_9_20_1","unstructured":"C.Collin F.Morand andF.Maurel \u201cWhy France is the Go\u2010To Country to Conduct Real\u2010World Studies \u201d2023."},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4983"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-013-0100-4"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-023-01382-5"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1742"},{"key":"e_1_2_9_25_1","unstructured":"Electronic Medicines Compendium \u201cAmoxicillin 500mg Capsules \u201d accessed September 28 2025 https:\/\/www.medicines.org.uk\/emc\/product\/526\/smpc."},{"key":"e_1_2_9_26_1","unstructured":"\u201cBase de donn\u00e9es publique des m\u00e9dicaments \u201dAMOXICILLINE ARROW LAB 500 mg g\u00e9lule accessed September 28 2025 https:\/\/base\u2010donnees\u2010publique.medicaments.gouv.fr\/medicament\/66916798\/extrait."},{"key":"e_1_2_9_27_1","unstructured":"Sant\u00e9 publique France \u201cConsommation d'antibiotiques en secteur de ville en France 2011\u20132021\u201d."},{"key":"e_1_2_9_28_1","unstructured":"A. C.P\u0103curariu \u201cThe Role of Signal Detection in Pharmacovigilance \u201d2018."},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1086\/431592"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16091571"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.17286"},{"key":"e_1_2_9_32_1","unstructured":"K.Hider\u2010MlynarzandC.\u2010O.Betansedi \u201cLa consommation des antibiotiques en France de 2000 a 2020 \u201d2023."},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-014-0198-z"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.70224","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T08:54:09Z","timestamp":1763715249000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.70224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1002\/pds.70224"],"URL":"https:\/\/doi.org\/10.1002\/pds.70224","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"2025-04-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70224"}}